Probability of care that meets minimum quality standards (%)
| Condition | (1) | (2) | (3) | (4) |
| Probability of care readiness | ||||
| As observed | Assume available drugs | Assume provider presence | No of facilities | |
| Diarrhoea | 51.9 | 57.7 | 61.7 | 7856 |
| (49.2 to 54.5) | (54.9 to 60.4) | (58.9 to 64.5) | ||
| Pneumonia | 39.3 | 50.9 | 46.7 | 7854 |
| (36.9 to 41.7) | (48.4 to 53.5) | (44.1 to 49.3) | ||
| Malaria | 62.5 | 77.9 | 71.6 | 4790 |
| (59.6 to 65.4) | (75.3 to 80.6) | (68.7 to 74.5) | ||
| Neonatal asphyxia | 58.8 | – | 70.5 | 7863 |
| (56.2 to 61.5) | (67.6 to 73.4) | |||
| Postpartum haemorrhage | 33.7 | 43.2 | 39.5 | 6438 |
| (31.5 to 35.8) | (40.8 to 45.7) | (37.1 to 41.8) | ||
| Child care | 27.9 | 36.4 | 33.1 | 7854 |
| (25.9 to 29.9) | (34.1 to 38.6) | (30.9 to 35.4) | ||
| Neonatal and maternal care | 29.0 | 37.1 | 34.2 | 6438 |
| (27.0 to 30.9) | (34.9 to 39.4) | (32.0 to 36.4) | ||
| Child, neonatal and maternal care | 13.7 | 19.1 | 16.6 | 6436 |
| (12.5 to 14.9) | (17.6 to 20.6) | (15.2 to 17.9) | ||
Column 1 reports the estimated probability of care readiness that meets minimum quality standards for different conditions (or set of conditions). Column 2 reports the estimated probability of care readiness that meets minimum quality standards, assuming essential drug(s) (oral rehydration salts or rehydration therapy for diarrhoea; antibiotics for pneumonia; artemisinin-based combination therapy for malaria; and oxytocin for postpartum haemorrhage) for treating the condition(s) are available. No essential drugs data were collected for neonatal asphyxia. Column 3 reports the estimated probability of care readiness that meets minimum quality standards, assuming no absenteeism. Child care includes two conditions (diarrhoea and pneumonia). Neonatal and maternity care includes two conditions (postpartum haemorrhage and neonatal asphyxia). Child, neonatal and maternity care includes four conditions (diarrhoea, pneumonia, postpartum haemorrhage and neonatal asphyxia). The estimates in the tables are (unweighted) mean outcomes across countries, with the country means calculated using country-specific sampling weights, with the 95% CI in parentheses (see text for details). Data are from clinical vignettes, unannounced visits, and visual inspections from Kenya (2018), Madagascar (2016), Mozambique (2014), Nigeria (2013), Niger (2017), Sierra Leone (2018), Tanzania (2016), Togo (2014), and Uganda (2013), with number of facilities reported in column 4. The malaria vignette was not used in the Kenya (2018) survey.